• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".

作者信息

Drosos Alexandros A, Pelechas Eleftherios, Drossou Vassiliki, Voulgari Paraskevi V

机构信息

Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.

出版信息

Rheumatol Ther. 2022 Aug;9(4):1233-1235. doi: 10.1007/s40744-022-00457-6. Epub 2022 May 27.

DOI:10.1007/s40744-022-00457-6
PMID:35622237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9136204/
Abstract
摘要

相似文献

1
A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".对以下内容的回复：致编辑的信，关于文章《秋水仙碱对抗新型冠状病毒感染：证据是什么？》
Rheumatol Ther. 2022 Aug;9(4):1233-1235. doi: 10.1007/s40744-022-00457-6. Epub 2022 May 27.
2
Letter to the Editor Regarding "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".致编辑的信：关于“秋水仙碱抗新型冠状病毒感染：证据何在？”
Rheumatol Ther. 2022 Aug;9(4):1229-1231. doi: 10.1007/s40744-022-00456-7. Epub 2022 Jun 13.
3
Letter to the Editor in response to the article 'Candidate drugs against SARS-CoV-2 and COVID-19'.致编辑的信：回应《抗SARS-CoV-2和COVID-19的候选药物》一文
Pharmacol Res. 2021 Jan;163:105285. doi: 10.1016/j.phrs.2020.105285. Epub 2020 Nov 4.
4
Letter to the Editor in response to the article: "Nebulization: a potential source of SARS-CoV-2 transmission".致编辑的信：回应文章《雾化：严重急性呼吸综合征冠状病毒2传播的潜在来源》
Respir Med Res. 2021 May;79:100802. doi: 10.1016/j.resmer.2020.100802. Epub 2020 Nov 17.
5
Letter to the editor regarding the article ''Rossi A, Magri F, Michelini S, et al. New onset of alopecia areata in a patient with SARS-COV-2 infection: Possible pathogenetic correlations? J Cosmet Dermatol. 2021 Mar 19. doi: 10.1111/jocd.14080".致编辑的信，关于文章“罗西 A、马格里 F、米凯利尼 S 等。一名感染 SARS-CoV-2 的患者新发斑秃：可能的发病机制关联？《美容皮肤病学杂志》。2021 年 3 月 19 日。doi:10.1111/jocd.14080”
J Cosmet Dermatol. 2021 Jun;20(6):1951-1952. doi: 10.1111/jocd.14155. Epub 2021 May 10.
6
Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.).对阿比普莎·苏尔·罗伊和阿莫尔·乔希就文章《英国生物银行中的多重疾病与SARS-CoV-2感染》（楚达萨马等人著）致编辑信的回复
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1281. doi: 10.1016/j.dsx.2020.06.034. Epub 2020 Jun 23.
7
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.信件1：对Sarkar博士等人致编辑的信的回复，信的主题为“谁说区分先兆子痫和新冠病毒感染很容易？”，涉及编号：S2210 - 7789(21)00539 - 0 信件2：对Hantoushzadeh博士等人致编辑的信的回复，信的主题为“新冠病毒疾病是先兆子痫的危险因素吗？这些患者是否应考虑使用阿司匹林预防先兆子痫？”，涉及编号：S2210 - 7789(21)00538 - 9
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
8
Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)' and 'Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.'.致编辑的信：回应文章《连花清瘟对新型冠状病毒（SARS-CoV-2）具有抗病毒和抗炎活性》及《六神胶囊通过抑制NF-κB信号通路显示出对新型冠状病毒SARS-CoV-2的抗病毒和抗炎能力》
Pharmacol Res. 2021 Jan;163:105289. doi: 10.1016/j.phrs.2020.105289. Epub 2020 Nov 13.
9
Response to Letter to the editor: Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".致编辑的信的回复：COVID-19患者的肺部超声——阴影多于信息——致编辑的信，关于文章“W. LU等人，《医学超声》，2020年4月15日”
Ultraschall Med. 2020 Aug;41(4):441-442. doi: 10.1055/a-1184-4807. Epub 2020 Jun 25.
10
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.秋水仙碱在COVID-19中应用的理论依据：对Cumhur Cure M等人信件的评论
Clin Rheumatol. 2020 Aug;39(8):2489-2490. doi: 10.1007/s10067-020-05232-y. Epub 2020 Jun 20.

本文引用的文献

1
Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area.在法国一个地方性流行区，342例接受秋水仙碱长期治疗的家族性地中海热患者的COVID-19临床病程。
Ann Rheum Dis. 2021 Apr;80(4):539-540. doi: 10.1136/annrheumdis-2020-218707. Epub 2020 Nov 2.